Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation.

Guo H, Xiang W, Zeng L, Xiao W, Sun L

Open source

DOI
10.3389/fimmu.2026.1981246
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1981246,
  title = {Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation.},
  author = {Guo H and Xiang W and Zeng L and Xiao W and Sun L},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1981246},
  url = {https://doi.org/10.3389/fimmu.2026.1981246}
}

RIS

TY  - JOUR
TI  - Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation.
AU  - Guo H
AU  - Xiang W
AU  - Zeng L
AU  - Xiao W
AU  - Sun L
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1981246
UR  - https://doi.org/10.3389/fimmu.2026.1981246
ER  - 

APA

H, G., W, X., L, Z., W, X., & L, S. (2026). Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1981246

Source records